Evidence map›Paper›PMID 29445920›Full record

ArticleMycopathologia2018

Phylogenetic Diversity and In Vitro Susceptibility Profiles of Human Pathogenic Members of the Fusarium fujikuroi Species Complex Isolated from South India.

Ananya Tupaki-Sreepurna, Vijayakishore Thanneru, Sangeetha Natarajan, Savitri Sharma, Anjana Gopi, Murugan Sundaram, Anupma Jyoti Kindo

Abstract read
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Genomic Insights intoPathogens (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Recent Advances in the Treatment of Scedosporiosis and Fusariosis.Journal of fungi (Basel, Switzerland) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ananya Tupaki-SreepurnaDepartment of Microbiology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra University, Porur, Chennai, Tamilnadu, 600116, India. ts.ananya@gmail.com.ORCID http://orcid.org/0000-0001-6665-1488
Vijayakishore ThanneruDepartment of Microbiology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra University, Porur, Chennai, Tamilnadu, 600116, India.
Sangeetha NatarajanDepartment of Microbiology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra University, Porur, Chennai, Tamilnadu, 600116, India.
Savitri SharmaJhaveri Microbiology Centre, LV Prasad Eye Institute, Kallam Anji Reddy Campus, L V Prasad Marg, Banjara Hills, Hyderabad, Telangana, 500034, India.
Anjana GopiDepartment of Microbiology, Kempegowda Institute of Medical Sciences, Athibabbe Road, Banashankari Stage II, Banashankari, Bengaluru, Karnataka, 560070, India.
Murugan SundaramDepartment of Dermatology, Venereology and Leprosy, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra University, Porur, Chennai, Tamilnadu, 600116, India.
Anupma Jyoti KindoDepartment of Microbiology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra University, Porur, Chennai, Tamilnadu, 600116, India.
Sri Ramachandra Institute of Higher Education and Research · INKempegowda Institute of Medical Sciences · INL V Prasad Eye Institute · IN

Funding

Indian Council of Medical Research SRU ICMR-TSS MD-PhD No.Ph.D.(Integrated)/-21-F.T./I/2012
6 · The paper itself

Abstract

Availability of molecular methods, gene sequencing, and phylogenetic species recognition have led to rare fungi being recognized as opportunistic pathogens. Fungal keratitis and onychomycosis are fairly common mycoses in the tropics, especially among outdoor workers and enthusiasts. The frequently isolated etiological agents belong to genera Candida, Aspergillus, and Fusarium. Within the genus Fusarium, known to be recalcitrant to prolonged antifungal treatment and associated with poor outcome, members of the Fusarium solani species complex are reported to be most common, followed by members of the Fusarium oxysporum SC and the Fusarium fujikuroi SC (FFSC). Morphological differentiation among the various members is ineffective most times. In the present study, we describe different species of the FFSC isolated from clinical specimen in south India. All twelve isolates were characterized up to species level by nucleic acid sequencing and phylogenetic analysis. The molecular targets chosen were partial regions of the internal transcribed spacer rDNA region, the panfungal marker and translation elongation factor-1α gene, the marker of choice for Fusarium speciation. Phylogenetic analysis was executed using the Molecular Evolutionary Genetics Analysis software (MEGA7). In vitro susceptibility testing against amphotericin B, voriconazole, posaconazole, natamycin, and caspofungin diacetate was performed following the CLSI M38-A2 guidelines for broth microdilution method. The twelve isolates of the FFSC were F. verticillioides (n = 4), F. sacchari (n = 3), F. proliferatum (n = 2), F. thapsinum (n = 1), F. andiyazi (n = 1), and F. pseudocircinatum (n = 1). To the best of our knowledge, this is the first report of F. andiyazi from India and of F. pseudocircinatum as a human pathogen worldwide. Natamycin and voriconazole were found to be most active agents followed by amphotericin B. Elderly outdoor workers figured more among the patients and must be recommended protective eye wear.

Indexed as

Genetic VariationPhylogenyAdultAntifungal AgentsCluster AnalysisDNA, FungalDNA, Ribosomal SpacerFemaleFusariosisFusariumHumansIndiaMaleMicrobial Sensitivity TestsMiddle AgedPeptide Elongation Factor 1Antifungal AgentsDNA, FungalDNA, Ribosomal SpacerPeptide Elongation Factor 1Antifungal susceptibility patternsF. andiyaziF. pseudocircinatumFusarium fujikuroi species complexPhylogenyTEF-1α

Identifiers

PMID29445920
OpenAlexW2793523556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.